Last update 12 Dec 2024
Camptothecin/Podophyllotoxin
Last update 12 Dec 2024
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms NEO 801, NEO-801, NEV-801 |
Target |
Mechanism TOP1 inhibitors(DNA topoisomerase I inhibitors), Tubulin inhibitors |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Structure
Molecular FormulaC20H16N2O4 |
InChIKeyVSJKWCGYPAHWDS-FQEVSTJZSA-N |
CAS Registry7689-03-4 |
View All Structures (2)
Related
1
Clinical Trials associated with Camptothecin/PodophyllotoxinA Phase 1, Open-Label, Dose-Escalation Study Evaluating the Safety, Pharmacokinetics, and Clinical Effects of Intravenously Administered NEV801 in Subjects With Advanced Malignancies
100 Clinical Results associated with Camptothecin/Podophyllotoxin
Login to view more data
100 Translational Medicine associated with Camptothecin/Podophyllotoxin
Login to view more data
100 Patents (Medical) associated with Camptothecin/Podophyllotoxin
Login to view more data
100 Deals associated with Camptothecin/Podophyllotoxin
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced cancer | Phase 1 | US | 01 Dec 2016 | |
| Solid tumor | Phase 1 | US | 01 Dec 2016 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Phase 1 | - | wnhnxcryxk(xlzrtmzpto) = futmtheihk jumcbmjdzw (qfjltijkwa ) View more | Positive | 01 Dec 2024 |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free